MTOR and cancer: Early on, metformin’s role in cancer clearly showed that AMPK-dependent inhibition of mTOR is required for multiple anti-cancer effects, as the phenotype can be rescued by targeting AMPK with siRNA or Compound C as well as constitutive activation of mTOR and short hairpin RNA targeting TSC2 [117,124,125,128,129].